MCAZ-PVCT-GL02-Rev-1_February 2022- PHARMACOVIGILANCE GUIDELINE FOR PHARMACEUTICAL INDUSTRY311 DownloadsDownload Now!Size: 622KB
View More MCAZ-PVCT-GL02-Rev-1_February 2022- PHARMACOVIGILANCE GUIDELINE FOR PHARMACEUTICAL INDUSTRYDownload Category: Guidelines
MCAZ-PVCT-GL-04-Rev-1-February 2022 Guidelines for Clinical Trial Application and Authorization in Zimbabwe
MCAZ-PVCT-GL-04-Rev-1-February 2022 Guidelines for Clinical Trial Application and Authorization in Zimbabwe238 DownloadsDownload Now!Size: 2MBPublished: March 22, 2022
View More MCAZ-PVCT-GL-04-Rev-1-February 2022 Guidelines for Clinical Trial Application and Authorization in ZimbabweMCAZ PVCT GL-05 Rev 2_February 2022 Guideline for Good Clinical Practice
MCAZ PVCT GL-05 Rev 2_February 2022 Guideline for Good Clinical Practice205 DownloadsDownload Now!Size: 665KBPublished: March 10, 2022
View More MCAZ PVCT GL-05 Rev 2_February 2022 Guideline for Good Clinical PracticeGL03-Rev-0_May-2021-Guideline for Pharmacovigilance of COVID-19 Vaccine AEFI Safety Surveillance
GL03-Rev-0_May-2021-Guideline for Pharmacovigilance of COVID-19 Vaccine AEFI Safety Surveillance189 DownloadsDownload Now!Size: 4 MBPublished: February 17, 2022
View More GL03-Rev-0_May-2021-Guideline for Pharmacovigilance of COVID-19 Vaccine AEFI Safety SurveillanceGuidelines_for_Conducting_Good_Clinical_Practice_GCP_Inspections_in_Zimbabwe__Rev_0_May_2021
Guidelines_for_Conducting_Good_Clinical_Practice_GCP_Inspections_in_Zimbabwe__Rev_0_May_2021358 DownloadsDOWNLOADSize: 504KB
View More Guidelines_for_Conducting_Good_Clinical_Practice_GCP_Inspections_in_Zimbabwe__Rev_0_May_2021Circular 16 of 2021 – Use of Ivermectin human oral formulations for prevention and or treatment of COVID 19
Circular 16 of 2021 – Use of Ivermectin human oral formulations for prevention and or treatment of COVID 19169 DownloadsDownload…
View More Circular 16 of 2021 – Use of Ivermectin human oral formulations for prevention and or treatment of COVID 19Zimbabwe National Pharmacovigilance Policy Handbook
Zimbabwe National Pharmacovigilance Policy Handbook292 DownloadsDOWNLOADSize: 5,786KBPublished: December 4, 2021
View More Zimbabwe National Pharmacovigilance Policy HandbookPharmacy guidelines for investigational medical products Version 1 June 2020
Pharmacy guidelines for investigational medical products Version 1 June 2020476 DownloadsDOWNLOADSize: 487KBPublished: December 4, 2021
View More Pharmacy guidelines for investigational medical products Version 1 June 2020e-PV External User Manual Revision 0_June 2020
e-PV External User Manual Revision 0_June 2020309 DownloadsDOWNLOADSize: 315KBPublished: December 4, 2021
View More e-PV External User Manual Revision 0_June 2020Guidelines for the Notification of Medicinal Product Problem or Defect and Recall Procedure
Guidelines for the Notification of Medicinal Product Problem or Defect and Recall Procedure198 DownloadsDOWNLOADSize: 735KBPublished: December 4, 2021
View More Guidelines for the Notification of Medicinal Product Problem or Defect and Recall Procedure